BCL2 and nasopharyngeal carcinoma: Thus, polymorphisms in BAX -248 G>A and BCL2 -938 C>A may lead to the changes in transcription factor binding towards the promoter, resulting in the altercation of gene expressions, which could be correlated with poor prognosis of the NPC patients’ survival.